MPMiles Paszek

Miles Paszek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Miles Paszek has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Shujuan Chen

    Laboratory of Environmental Toxicology, Department of Pharmacology, University of California, San Diego, La Jolla, California

    4 shared publications
  • Robert H. Tukey

    Laboratory of Environmental Toxicology, Department of Pharmacology, University of California, San Diego, La Jolla, USA

    3 shared publications
  • Eva Rettenmeier

    Laboratory of Environmental Toxicology, Department of Pharmacology, University of California, San Diego, La Jolla, California (W.L., E.R., M.P., M-F.Y., R.H.T., S.C.); and Laboratory of Molecular Pharmacology, CHU de Quebec Research Centre and Faculty of Pharmacy, Laval University, Québec (Québec), Canada (J.T., O.B.).

    2 shared publications
  • Mei-Fei Yueh

    Laboratory of Environmental Toxicology, Department of Pharmacology, University of California, San Diego, La Jolla, California (W.L., E.R., M.P., M-F.Y., R.H.T., S.C.); and Laboratory of Molecular Pharmacology, CHU de Quebec Research Centre and Faculty of Pharmacy, Laval University, Québec (Québec), Canada (J.T., O.B.).

    2 shared publications
  • Camille Konopnicki

    Laboratory of Environmental Toxicology, Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA

    1 shared publication
  • Christopher Benner

    Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California

    1 shared publication

Latest Publications

  • Open Access

    NCoR1 Protects Mice From Dextran Sodium Sulfate–Induced Colitis by Guarding Colonic Crypt Cells From Luminal Insult

    by Elvira Mennillo, Xiaojing Yang, Miles Paszek, Johan Auwerx, Christopher Benner, Shujuan Chen


  • NRF2-Independent Regulation of Intestinal Constitutive Androstane Receptor by the Pro-Oxidants Cadmium and Isothiocyanate in hUGT1 Mice

    by Miles Paszek, Robert H. Tukey

    Environmental toxicants such as heavy metals from contaminated water or soil and isothiocyanates (ITC) from dietary sources act as pro-oxidants by directly generating reactive oxygen species (ROS) or through depleting cellular antioxidants such as glutathione. Toxicants can alter drug metabolism, and it was reported that CYP2B10 and UGT1A1 are induced by phenethyl isothiocyanate (PEITC) through the constitutive androstane receptor (CAR). The possibility that nuclear factor erythroid 2-related factor 2 (NRF2), the master regulator of the antioxidant response, could coactivate CAR was investigated in neonatal hUGT1/Nrf2−/− mice. Neonatal mice were treated with PEITC or cadmium (Cd2+) by oral gavage for 2 days. Both PEITC and Cd2+ induced UGT1A1 RNA and protein in intestinal tissues in both hUGT1/Nrf2+/− and hUGT1/Nrf2−/− neonates, indicating NRF2-independent regulation of UGT1A1. Increases in CYP2B10 RNA in intestinal tissues were observed following PEITC or Cd2+ exposure. Activation of intestinal CAR by Cd2+ exposure was directly assessed by nuclear fractionation and Western blot analyses at 0.5, 1, 2, and 4 hours after treatment in hUGT1 neonates and after 48 hours in hUGT1/Nrf2+/− and hUGT1/Nrf2−/− neonates. CAR localized to the nucleus independently of NRF2 48 hours after exposure. Substantial CAR localization to the nucleus occurred at the 2- and 4-hour time points, coinciding with a decrease in phosphorylation of cytoplasmic extracellular signal-regulated kinases 1 and 2 and a nuclear increase in P38/p-P38 content. This suggests that a novel oxidative stress-MAPK-CAR axis exists with phenotypic consequences. SIGNIFICANCE STATEMENT Pro-oxidant toxicants can alter drug metabolism through activation of CAR, independent of the NRF2-KEAP1 signaling pathway. Changes in proteins associated with drug metabolism and linked to increases in intestinal maturation are mediated through an oxidative stress-MAPK-CAR axis.


  • Crypt Organoid Culture as an In Vitro Model in Drug Metabolism and Cytotoxicity Studies

    by Wenqi Lu, Eva Rettenmeier, Miles Paszek, Mei-Fei Yueh, Robert H. Tukey, Jocelyn Trottier, Olivier Barbier, Shujuan Chen

    The gastrointestinal tract is enriched with xenobiotic processing proteins that play important roles in xenobiotic bioactivation, metabolism, and detoxification. The application of genetically modified mouse models has been instrumental in characterizing the function of xenobiotic processing genes (XPG) and their proteins in drug metabolism. Here, we report the utilization of three-dimensional crypt organoid cultures from these animal models to study intestinal drug metabolism and toxicity. With the successful culturing of crypt organoids, we profiled the abundance of Phase I and Phase II XPG expression, drug transporter gene expression, and xenobiotic nuclear receptor (XNR) gene expression. Functions of XNRs were examined by treating crypt cells with XNR prototypical agonists. Real-time quantitative polymerase chain reaction demonstrated that the representative downstream target genes were induced. These findings were validated from cultures developed from XNR-null mice. In crypt cultures isolated from Pxr−/− mice, pregnenolone 16α-carbonitrile failed to induce Cyp3a11 gene expression; similarly, WY14643 failed to induce Cyp4a10 in the Pparα−/− crypts. Crypt cultures from control (Ugt1F/F) and intestinal epithelial cell (IEC) specific Ugt1 null mice (Ugt1ΔIEC) were treated with camptothecin-11, an anticancer prodrug with severe intestinal toxicity that originates from insufficient UGT1A1-dependent glucuronidation of its active metabolite SN-38. In the absence of Ugt1 gene expression, Ugt1ΔIEC crypt cultures exhibit very limited production of SN-38 glucuronide, concordant with increased apoptosis in comparison with Ugt1F/F crypt cultures. This study suggests crypt organoid cultures as an effective in vitro model for studying intestinal drug metabolism and toxicity.


  • Open Access

    Isothiocyanates induce UGT1A1 in humanized UGT1 mice in a CAR dependent fashion that is highly dependent upon oxidative stress

    by Emiko Yoda, Miles Paszek, Camille Konopnicki, Ryoichi Fujiwara, Shujuan Chen, Robert H. Tukey

    Isothiocyanates, such as phenethyl isothiocyanate (PEITC), are formed following the consumption of cruciferous vegetables and generate reactive oxygen species (ROS) that lead to the induction of cytoprotective genes such as the UDP-glucuronosyltransferases (UGTs). The induction of ROS activates the Nrf2-Keap 1 pathway leading to the induction of genes through antioxidant response elements (AREs). UGT1A1, the sole enzyme responsible for the metabolism of bilirubin, can be induced following activation of Nrf2. When neonatal humanizedUGT1 (hUGT1) mice, which exhibit severe levels of total serum bilirubin (TSB) because of a developmental delay in expression of theUGT1A1gene, were treated with PEITC, TSB levels were reduced. Liver and intestinal UGT1A1 were induced, along with murine CYP2B10, a consensus CAR target gene. In both neonatal and adulthUGT1/Car−/−mice, PEITC was unable to induce CYP2B10. A similar result was observed following analysis of UGT1A1 expression in liver. However, TSB levels were still reduced inhUGT1/Car−/−neonatal mice because of ROS induction of intestinal UGT1A1. When oxidative stress was blocked by exposing mice to N-acetylcysteine, induction of liver UGT1A1 and CYP2B10 by PEITC was prevented. Thus, new findings in this report link an important role in CAR activation that is dependent upon oxidative stress.


  • Open Access

    Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia

    by Shujuan Chen, Wenqi Lu, Mei-Fei Yueh, Eva Rettenmeier, Miao Liu, Miles Paszek, Johan Auwerx, Ruth T. Yu, Ronald M. Evans, Kepeng Wang, et al.

    Significance: In many parts of the world, especially in low- and middle-income countries, severe neonatal hyperbilirubinemia (SNH) is associated with substantial mortality and long-term morbidities. Although the immediate and rapid rise in total serum bilirubin (TSB) originating from lysis of red blood cells has been linked to genetic predisposition, preterm births, and blood type incompatibilities, the inability to efficiently metabolize bilirubin results from delayed expression of UDP-glucuronosyltransferase 1A1 (UGT1A1). In this study, the mechanism associated with delayed expression of the humanUGT1A1gene in neonatal mice that are humanized for theUGT1locus is described. Neonatal humanizedUGT1(hUGT1) mice develop SNH and control TSB levels by nuclear receptor corepressor 1 (NCoR1)-directed repression of intestinal epithelial cell maturation, an event linked to expression of theUGT1A1gene.